PIK3CA and non-small cell lung carcinoma: The RAS/RAF/MAPK/ERK and PI3K/AKT pathways are considered the two most common cascade signaling pathways involved in bypass activation, and mutations or amplifications in key genes in these two pathways can mediate NSCLC TKI resistance (31, 32, 34, 152).